Corcept Therapeutics Incorporated
CORT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $141 | $106 | $101 | $113 |
| Dep. & Amort. | $1 | $2 | $3 | $3 |
| Deferred Tax | -$40 | -$29 | -$34 | $4 |
| Stock-Based Comp. | $61 | $49 | $42 | $43 |
| Change in WC | $45 | $8 | $6 | -$0 |
| Other Non-Cash | -$11 | -$9 | $1 | $5 |
| Operating Cash Flow | $198 | $127 | $120 | $168 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | -$137 |
| Inv. Purchases | -$588 | -$329 | -$355 | -$313 |
| Inv. Sales/Matur. | $413 | $420 | $241 | $449 |
| Other Inv. Act. | $0 | $0 | $0 | $137 |
| Investing Cash Flow | -$178 | $91 | -$114 | $136 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $10 | $0 | $0 | $0 |
| Stock Repurch. | -$16 | -$145 | $0 | -$296 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$22 | -$3 | -$17 | -$7 |
| Financing Cash Flow | -$28 | -$149 | -$17 | -$303 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$8 | $69 | -$11 | $1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $136 | $66 | $78 | $76 |
| End Cash | $128 | $136 | $66 | $78 |
| Free Cash Flow | $196 | $127 | $120 | $167 |